Subtopic Deep Dive

← Phenothiazines and Benzothiazines Synthesis and Activities

Phenothiazine Antimicrobial Activity
Research Guide

What is Phenothiazine Antimicrobial Activity?

Phenothiazine antimicrobial activity refers to the capacity of phenothiazine compounds to inhibit bacterial efflux pumps, enhance antibiotic efficacy, and combat multidrug-resistant pathogens.

Phenothiazines like promethazine and thioridazine act as efflux pump inhibitors (EPIs) against NorA in Staphylococcus aureus and AcrAB-TolC in Gram-negative bacteria (Varga et al., 2017; Amaral et al., 2014). Studies demonstrate synergy with antibiotics, reducing minimum inhibitory concentrations (MICs) in MDR strains (Spengler et al., 2017). Over 10 papers from 2008-2020 document these effects, with clinical repurposing potential (Lagadinou et al., 2020).

Curated Papers

Key Challenges

Why It Matters

Phenothiazines address antimicrobial resistance by inhibiting efflux pumps in pathogens like S. aureus and Pseudomonas aeruginosa, restoring antibiotic susceptibility (Amaral et al., 2014; Spengler et al., 2017). Sertraline potentiates antimicrobials against clinical isolates, offering repurposing for MDR infections (Ayaz et al., 2015). Varga et al. (2017) highlight phenothiazines' broad applications against Gram-positive and Gram-negative bacteria, biofilms, and even fungi, reducing reliance on new antibiotics amid global resistance crises (Kourtesi et al., 2013; Lagadinou et al., 2020).

Key Research Challenges

Efflux Pump Specificity

Phenothiazines inhibit multiple pumps but lack selectivity, risking off-target effects on human transporters (Amaral et al., 2014). Martins et al. (2013) describe methods to assess over-expressed pumps, yet optimizing for NorA vs. AcrAB-TolC remains difficult.

Synergy Quantification

Measuring true EPI synergy versus intrinsic antimicrobial activity requires advanced assays like checkerboard MICs (Spengler et al., 2017). Ayaz et al. (2015) show sertraline's enhancement, but standardizing across strains challenges reproducibility.

Clinical Translation Barriers

Despite in vitro promise, toxicity and pharmacokinetics limit phenothiazine repurposing (Varga et al., 2017). Kourtesi et al. (2013) note implementation hurdles from lab to clinic for efflux inhibitors.

Essential Papers

Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus

Nitin Pal Kalia, Priya Mahajan, Rukmankesh Mehra et al. · 2012 · Journal of Antimicrobial Chemotherapy · 210 citations

This study, for the first time, has shown that capsaicin, a novel EPI, not only inhibits the NorA efflux pump of S. aureus but also reduces the invasiveness of S. aureus, thereby reducing its virul...

New Roads Leading to Old Destinations: Efflux Pumps as Targets to Reverse Multidrug Resistance in Bacteria

Gabriella Spengler, Annamária Kincses, Márió Gajdács et al. · 2017 · Molecules · 183 citations

Multidrug resistance (MDR) has appeared in response to selective pressures resulting from the incorrect use of antibiotics and other antimicrobials. This inappropriate application and mismanagement...

Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria

Yiannis C. Fiamegos, Panagiotis L. Kastritis, Vassiliki Exarchou et al. · 2011 · PLoS ONE · 182 citations

These techniques facilitated the direct analysis of the active components from plant extracts, as well as dramatically reduced the time needed to analyze the compounds, without the need for prior i...

Novel structural analogues of piperine as inhibitors of the NorA efflux pump of Staphylococcus aureus

Ashwani Kumar, Inshad Ali Khan, Supriya Koul et al. · 2008 · Journal of Antimicrobial Chemotherapy · 165 citations

A newly identified class of compounds derived from a natural amide, piperine, is more potent than the parent molecule in potentiating the activity of ciprofloxacin through the inhibition of the Nor...

Efflux pumps of Gram-negative bacteria: what they do, how they do it, with what and how to deal with them

Leonard Amaral, Ana Martins, Gabriella Spengler et al. · 2014 · Frontiers in Pharmacology · 163 citations

This review discusses the relationship of the efflux pump (EP) system of Gram-negative bacteria to other antibiotic resistance mechanisms of the bacterium such as quorum sensing, biofilms, two comp...

Microbial Efflux Systems and Inhibitors: Approaches to Drug Discovery and the Challenge of Clinical Implementation

Christina Kourtesi, Anthony R. Ball, Ying‐Ying Huang et al. · 2013 · The Open Microbiology Journal · 154 citations

Conventional antimicrobials are increasingly ineffective due to the emergence of multidrug-resistance among pathogenic microorganisms. The need to overcome these deficiencies has triggered explorat...

Sertraline enhances the activity of antimicrobial agents against pathogens of clinical relevance

Muhammad Ayaz, Fazal Subhan, Jawad Ahmed et al. · 2015 · Journal of Biological Research - Thessaloniki · 135 citations

Reading Guide

Foundational Papers

Start with Amaral et al. (2014, 163 citations) for Gram-negative efflux mechanisms and Varga et al. (2017, 135 citations) for phenothiazine overview, as they establish core EPI concepts and applications.

Recent Advances

Study Lagadinou et al. (2020, 116 citations) for non-antibiotic repurposing and Ayaz et al. (2015, 135 citations) for sertraline data, capturing translation advances.

Core Methods

Efflux inhibition via etBr assays (Martins et al., 2013); MIC synergy checkerboards (Ayaz et al., 2015); docking for binding (Fiamegos et al., 2011).

How PapersFlow Helps You Research Phenothiazine Antimicrobial Activity

Discover & Search

PapersFlow's Research Agent uses searchPapers and exaSearch to find phenothiazine EPI studies, revealing citationGraph clusters around Amaral et al. (2014) with 163 citations linking to Spengler et al. (2017). findSimilarPapers expands to Varga et al. (2017) on clinical applications.

Analyze & Verify

Analysis Agent employs readPaperContent on Ayaz et al. (2015) to extract MIC synergy data, then runPythonAnalysis with pandas to compute fold-reductions across datasets. verifyResponse (CoVe) and GRADE grading confirm EPI claims against Martins et al. (2013) assays, with statistical verification of p-values from efflux inhibition experiments.

Synthesize & Write

Synthesis Agent detects gaps in phenothiazine biofilm studies via contradiction flagging between Kourtesi et al. (2013) and recent works. Writing Agent uses latexEditText, latexSyncCitations for Varga et al. (2017), and latexCompile to generate MIC tables; exportMermaid diagrams efflux pump networks.

Use Cases

"Analyze sertraline synergy MICs from Ayaz 2015 against S. aureus strains"

Analysis Agent → readPaperContent (Ayaz et al., 2015) → runPythonAnalysis (pandas fold-change calculation, matplotlib MIC plots) → researcher gets CSV of synergy ratios and statistical significance.

"Draft LaTeX review on phenothiazine EPIs with citations"

Synthesis Agent → gap detection (Spengler et al., 2017) → Writing Agent → latexEditText (structure sections) → latexSyncCitations (10 papers) → latexCompile → researcher gets compiled PDF with figures.

"Find GitHub code for NorA efflux pump simulations"

Research Agent → searchPapers (NorA models) → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → researcher gets repo links with docking scripts linked to Fiamegos et al. (2011).

Automated Workflows

Deep Research workflow scans 50+ papers on phenothiazine EPIs: searchPapers → citationGraph (Amaral cluster) → DeepScan (7-step verify MIC data via CoVe) → structured report with GRADE scores. Theorizer generates hypotheses on phenothiazine-biofilm interactions from Varga et al. (2017) + Kourtesi et al. (2013), chaining gap detection to exportMermaid diagrams. DeepScan applies checkpoints to validate synergy claims in Ayaz et al. (2015).

Try Doxa for Phenothiazine Antimicrobial Activity Research

Frequently Asked Questions

What defines phenothiazine antimicrobial activity?

Phenothiazines inhibit bacterial efflux pumps like NorA, potentiate antibiotics, and reduce MICs in MDR pathogens (Varga et al., 2017; Spengler et al., 2017).

What methods assess phenothiazine EPI activity?

Checkerboard assays measure synergy; etBr accumulation tests efflux inhibition (Martins et al., 2013; Amaral et al., 2014).

What are key papers on this topic?

Varga et al. (2017, 135 citations) reviews phenothiazine applications; Ayaz et al. (2015, 135 citations) shows sertraline synergy; Spengler et al. (2017, 183 citations) targets MDR reversal.